Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

IndiaMART InterMESH Ltd - 542726 - Board Meeting Intimation for The Approval The Audited Standalone And Consolidated Financial Results ('Financial Results') Of The Company For The Quarter And Nine Months Ended December 31, 2023.

 Indiamart Intermesh Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/01/2024 ,inter alia, to consider and approve the Audited Standalone and Consolidated Financial Results ('Financial Results') of the Company for the quarter and nine months ended December 31, 2023.
11-01-2024
Bigul

IndiaMART InterMESH Ltd - 542726 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arisaig Asia Fund Ltd & Others
02-01-2024
Bigul

IndiaMART InterMESH Ltd - 542726 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 ln accordance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the schedule of analyst/ institutional investor meet/call(s). During the said meet/call(s), no unpublished price sensitive information was shared. The latest Investor Presentation is available on the website of the Company at https://investor.indiamart.com/FinancialResultsStatements.aspx
28-12-2023
Bigul

IndiaMART InterMESH Ltd - 542726 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 ln accordance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the schedule of analyst/ institutional investor meet/call. During the said meet/call, no unpublished price sensitive information was shared. The latest Investor Presentation is available on the website of the Company at https://investor.indiamart.com/FinancialResultsStatements.aspx
27-12-2023
Bigul

IndiaMART InterMESH Ltd - 542726 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 ln accordance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the schedule of analyst/ institutional investor meet/call. During the said meet/call, no unpublished price sensitive information was shared. The latest Investor Presentation is available on the website of the Company at https://investor.indiamart.com/FinancialResultsStatements.aspx
26-12-2023

Equirus Securities expects 17% upside in IndiaMart by March 2025

 The brokerage said IndiaMART is trading at a premium to multiples of classifieds-based models listed globally and in India, barring Info Edge. But its premium valuations are justified, given a healthy earnings growth outlook, strong cash generating abilities, and superior returns profile, it said.
26-12-2023
Bigul

IndiaMART InterMESH Ltd - 542726 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 ln accordance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the schedule of analyst/ institutional investor meet/call(s). During the said meet/call(s), no unpublished price sensitive information was shared. The latest Investor Presentation is available on the website of the Company at https://investor.indiamart.com/FinancialResultsStatements.aspx
22-12-2023
Bigul

IndiaMART InterMESH Ltd - 542726 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 ln accordance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the schedule of analyst/ institutional investor meet/call(s). During the said meet/call(s), no unpublished price sensitive information was shared. The latest Investor Presentation is available on the website of the Company at https://investor.indiamart.com/FinancialResultsStatements.aspx
20-12-2023
Bigul

IndiaMART InterMESH Ltd - 542726 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 ln accordance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the schedule of analyst/ institutional investor meet/call. During the said meet/call, no unpublished price sensitive information was shared. The latest Investor Presentation is available on the website of the Company at https://investor.indiamart.com/FinancialResultsStatements.aspx
19-12-2023
Bigul

IndiaMART is working with Novo Nordisk to halt illegal Wegovy sales

 Novo Nordisk is the sole patent holder of semaglutide, the active ingredient in both Wegovy and Ozempic, which are not yet approved for sale in India
18-12-2023
Next Page
Close

Let's Open Free Demat Account